BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36241191)

  • 21. Does hypereosinophilic syndrome precede common B acute lymphoblastic leukaemia in childhood? A case report.
    Ayhan AC; Timur C; Ayhan Y; Cakır B; Erguven M
    Acta Haematol; 2012; 127(2):90-2. PubMed ID: 22156491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Two patients with hypereosinophilic syndrome].
    van Ruth S; Lokhorst HM; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2006 May; 150(21):1193-7. PubMed ID: 16768285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed Infarction.
    Tennenbaum J; Groh M; Venditti L; Campos-Gazeau F; Chalayer E; De Broucker T; Hamidou M; Hunault M; Lyoubi A; Meunier R; Muron T; Sène D; Slama B; Guidoux C; Lefèvre G; Kahn JE; Denier C; Rohmer J
    Stroke; 2021 Oct; 52(10):e605-e609. PubMed ID: 34304603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypereosinophilic syndrome preceding a diagnosis of B-cell lymphoma.
    Samarghandi A; Ahuja S; Jindal V; Gupta S; Fulger I
    Tumori; 2018 Dec; 104(6):NP22-NP24. PubMed ID: 29714651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Causes of hypereosinophilia in 100 consecutive patients.
    Moller D; Tan J; Gauiran DTV; Medvedev N; Hudoba M; Carruthers MN; Dehghan N; van den Berghe J; Bruyère H; Chen LYC
    Eur J Haematol; 2020 Sep; 105(3):292-301. PubMed ID: 32364630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of paediatric idiopathic hypereosinophilia.
    Rapanotti MC; Caruso R; Ammatuna E; Zaza S; Trotta L; Divona M; Cicconi L; Funaro D; Federici G; Amadori S; De Rossi G; Lo-Coco F
    Br J Haematol; 2010 Dec; 151(5):440-6. PubMed ID: 20955401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cough and hypereosinophilia due to FIP1L1-PDGFRA fusion gene with tyrosine kinase activity.
    Chung KF; Hew M; Score J; Jones AV; Reiter A; Cross NC; Bain BJ
    Eur Respir J; 2006 Jan; 27(1):230-2. PubMed ID: 16387954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Approach to the Evaluation of Persistent Hypereosinophilia in Pediatric Patients.
    Schwartz JT; Fulkerson PC
    Front Immunol; 2018; 9():1944. PubMed ID: 30233571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [FIP1L1::PDGFRA-positive chronic eosinophilic leukemia showing slowly progressive cardiac impairment].
    Shimizu M; Kuroda A; Suyama T; Seki M; Shinagawa A
    Rinsho Ketsueki; 2022; 63(12):1648-1652. PubMed ID: 36653138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy.
    Pardanani A; Ketterling RP; Brockman SR; Flynn HC; Paternoster SF; Shearer BM; Reeder TL; Li CY; Cross NC; Cools J; Gilliland DG; Dewald GW; Tefferi A
    Blood; 2003 Nov; 102(9):3093-6. PubMed ID: 12842979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identification of FIP1L1-PDGFRA fusion, and expression of signal transducer and activator of transcription 5 in hypereosinophilic syndrome].
    Zhang GS; Li B; Pei MF; Dai CW; Zheng WL; Shen JK
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1541-4. PubMed ID: 15500716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management.
    Gotlib J; Cools J; Malone JM; Schrier SL; Gilliland DG; Coutré SE
    Blood; 2004 Apr; 103(8):2879-91. PubMed ID: 15070659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. When Blood Cell Counts Matter: Hypereosinophilic Syndrome as a Rare Cause of Ischemic Strokes.
    Kaur G; Rodriguez W; Ganev Y; Singh D; Awad A; Orozco L; Overberg R; Edgell RC
    Cureus; 2024 May; 16(5):e60557. PubMed ID: 38887335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of hypereosinophilic syndrome: a prospective study in the era of molecular genetics.
    Dahabreh IJ; Giannouli S; Zoi C; Zoi K; Voulgarelis M; Moutsopoulos HM
    Medicine (Baltimore); 2007 Nov; 86(6):344-354. PubMed ID: 18004179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of myeloid neoplasms associated with PDGFRA rearrangement with imatinib mesylate.
    Sun CY; Hu Y; Chu ZB; Guo T; He J
    Int J Hematol; 2009 Jan; 89(1):66-70. PubMed ID: 19096755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The FIP1L1-PDGFRalpha kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia.
    Cools J; Stover EH; Wlodarska I; Marynen P; Gilliland DG
    Curr Opin Hematol; 2004 Jan; 11(1):51-7. PubMed ID: 14676627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urticarial lesions in a child with acute lymphoblastic leukemia and eosinophilia.
    Hill A; Metry D
    Pediatr Dermatol; 2003; 20(6):502-5. PubMed ID: 14651570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome.
    Weyand AC; Yanik GA; Bailey NG; Wu YM; Mody RJ; Castle VP
    Pediatr Blood Cancer; 2016 Jan; 63(1):164-7. PubMed ID: 26257279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel acquired cryptic three-way translocation t(2;11;5)(p21.3;q13.5;q23.2) with a submicroscopic deletion at 11p14.3 in an adult with hypereosinophilic syndrome.
    Kjeldsen E
    Exp Mol Pathol; 2015 Aug; 99(1):50-5. PubMed ID: 25962659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An 85-Year-Old Man with Fever, Dyspnea, and Dry Cough Diagnosed with Idiopathic Hypereosinophilic Syndrome, Successfully Treated with High-Dose Corticosteroids.
    Goyal P; Chhabra ST; Tandon R; Jaiswal B; Sharma N
    Am J Case Rep; 2023 Dec; 24():e941241. PubMed ID: 38073150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.